Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, China; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, 100191, China; Therapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, 100191, China.
Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, China; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, 100191, China; Therapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, 100191, China; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.
Res Social Adm Pharm. 2021 Jan;17(1):2027-2031. doi: 10.1016/j.sapharm.2020.03.027. Epub 2020 Apr 3.
To discuss hospital pharmacists' role in providing pharmaceutical care for hospitalized patients with COVID-19 to promote patient care and management during the pandemic.
Based on the method of evidence-based pharmacy, clinical evidence of therapeutical drugs for COVID-19 were retrieved and summarized. Based on clinical experience Chinese hospital pharmacists gained from providing pharmaceutical care services during COVID-19 pandemic, taking COVID-19 hospitalized patients' needs into consideration, the methods and strategies hospital pharmacists shall use to provide pharmaceutical care were analyzed and summarized.
Hospital pharmacists shall support pharmaceutical care services by participating in making evidence-based decisions for medication, monitoring and evaluation of medication safety and efficacy, providing strengthened care for special population and patients with combined underlying diseases, monitoring and management of convalescent plasma therapy, providing emotional counselling and psychological support, and providing scientific information about COVID-19 vaccines.
The need of pharmaceutical care services in COVID-19 hospitalized patients during this pandemic was quite distinguished from the past. Hospital pharmacists shall join the collaborative multidisciplinary team to improve COVID-19 patients' outcome and reduce mortality, and to facilitate the pandemic control.
探讨医院药师在为 COVID-19 住院患者提供药学服务中的作用，以促进大流行期间的患者护理和管理。
基于循证药学方法，检索并总结了治疗 COVID-19 的治疗药物的临床证据。基于中国医院药师在 COVID-19 大流行期间提供药学服务所获得的临床经验，并考虑 COVID-19 住院患者的需求，分析和总结了药师提供药学服务的方法和策略。
医院药师应通过参与制定基于证据的药物治疗决策、监测和评估药物的安全性和疗效、为特殊人群和合并基础疾病的患者提供强化护理、监测和管理恢复期血浆治疗、提供关于 COVID-19 疫苗的情绪咨询和心理支持、提供 COVID-19 相关的科学信息等方式来支持药学服务。
COVID-19 住院患者在大流行期间对药学服务的需求与以往有很大不同。医院药师应加入多学科协作团队，以改善 COVID-19 患者的结局并降低死亡率，促进疫情控制。
